Selamectin Synthesis via Manganese Dioxide Oxidation and One-Step Desugarization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current synthesis methods for selamectin face challenges such as low yield, high cost, and complex post-treatment operations due to the use of precious metal catalysts and multiple solvent-intensive steps, making them inefficient for commercial production.
Innovation Solution
A modified synthesis method involving initial oxidation of doramectin using manganese dioxide, followed by a one-step desugarization and oximation reaction with hydroxylamine hydrochloride, and final hydrogenation with a reduced catalyst load, optimizing the use of solvents and simplifying the process to enhance yield and purity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If the conventional synthesis method using Wilkinson's catalyst and multiple separation steps is employed, then the reaction can proceed, but the process cost increases and the operation complexity increases
Solution Approach 1:
The patent removes the expensive Wilkinson's catalyst and complex silica gel chromatography separation steps from the conventional synthesis route. Instead, it employs a one-pot desugarization-oximation reaction that eliminates the need for precious metal catalysts and complex separation operations, directly addressing the cost and complexity issues.
Solution Approach 2:
The patent combines desugarization and oximation reactions into a single one-pot operation, merging two separate steps into one. This integration eliminates intermediate isolation and reduces the number of operation steps, thereby simplifying the overall process and reducing costs.
2Productivity
If the conventional four-step synthesis route with multiple chromatography separations is used, then the reaction proceeds through each step, but the productivity decreases
Solution Approach 1:
The patent merges desugarization and oximation into a single reaction step, reducing the total number of steps from four to two. This consolidation eliminates time-consuming intermediate isolations and chromatography separations, significantly improving productivity and reducing production time.
Solution Approach 2:
The patent performs desugarization first to remove the sugar moiety, creating a more reactive intermediate that undergoes oximation more efficiently. This preliminary action prepares the substrate for the subsequent oximation step, improving overall reaction efficiency and yield.
3Manufacturing precision
If DMP oxidizing agent and multiple washing steps are employed, then the oxidation reaction proceeds, but the post-treatment becomes complicated and time-consuming
Solution Approach 1:
The patent removes DMP (a complex oxidizing agent requiring multiple washing steps with sodium thiosulfate, hydrochloric acid, sodium hydroxide, and saturated brine) from the synthesis route. Instead, it uses manganese dioxide, which requires only simple filtration and neutralization, dramatically simplifying post-treatment while maintaining oxidation efficiency.
4Adaptability or versatility
If high boiling solvents like 1,4-dioxane are used in large quantities, then the reactions can be carried out, but the solvent cost and environmental burden increase
Solution Approach 1:
The patent changes the solvent system from high-boiling solvents like 1,4-dioxane to lower-boiling, more environmentally friendly solvents. The oxidation step uses dichloromethane/methanol, while the one-pot desugarization-oximation uses ethanol/water, reducing solvent consumption and simplifying solvent removal.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The new method achieves a higher yield of up to 57% with 97.11% purity, reduces solvent costs, and streamlines the production process, making it more suitable for industrial production while meeting pharmacopoeia standards.
Implementation Method 1
reacting doramectin in the presence of manganese dioxide (MnO2) at room temperature (20-30° C.) for 7-14 hours
Implementation Method 2
adding an aqueous solution of hydroxylamine hydrochloride dropwise, and carrying out the desugaroximation reaction
Implementation Method 3
desugarization hydrolysis and oximation
Implementation Method 4
introducing 3-4 bar hydrogen, and reacting the intermediate C in the presence of 4-8% w/w Wilkinson's catalyst at 30° C. for 8 hours
Data Source
AI summary
A synthesis method for selamectin was developed, where doramectin is oxidized by manganese dioxide, oximated and de-sugared in one-step by an aqueous solution of hydroxylamine hydrochloride, and then selectively reduced in the presence of Wilkinson's catalyst and hydrogen to obtain selamectin. Doramectin is oxidized to a carbonyl group firstly, so that the generation of impurities during the subsequent reaction is reduced; t-butyl alcohol with a larger steric hindrance is used as a solvent, so that transesterification impurities are avoided; the hydrogenation is implemented in the final step, and the crude product is recrystallized before the hydrogenation reaction, so that the cost is greatly reduced. The method of the present application with an overall yield of 57%. The purity of product was 97.11%. All impurities meet the requirements of Pharmacopoeia. The present application is a simpler, more economical and more efficient synthesis method, and is suitable for industrial production.